ZyCoV-D vaccine trial: Zydus Cadila seeks govt nod to start Phase-III clinical trials of COVID-19 vaccine

The company's "plasmid DNA vaccine to prevent COVID-19, ZyCoV-D, was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials. The company is now planning to initiate Phase III clinical trials in around 30,000 volunteers upon receiving necessary approvals," Zydus Cadila said in a statement.

from Lifestyle News:Entertainment News,Bollywood Latest News,Box Office Collection Report,Movie Reviews
Read The Rest:financialexpress...